RetinalGenix Technologies Inc.
RTGN · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $29 | $54 | $140 | $43 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $1 | $0 | $0 |
| Enterprise Value | $29 | $54 | $140 | $43 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$2 | -$4 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$2 | -$4 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.12 | -0.25 | -0.15 |
| % Growth | -100% | 52% | -66.7% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$1 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$1 |